Approval · Notice of Compliance 26660 · 2021
TENOXICAM: Notice of Compliance 26660
Issued September 16, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26660
- Date
- September 16, 2021
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Transfer of Product Ownership. Updates to Product Monograph. Updates to Bottle Labels. Change in Brand Name
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TENOXICAM | 02230510 | Approved |
Medicinal ingredients
- TENOXICAM 20 MG per TAB